Try our Advanced Search for more refined results

CytRx Using Forum Flip-Flop To Stall Del. Case, Investors Say

By Jeff Montgomery (April 18, 2016, 11:43 PM EDT) -- Counsel for a class of Delaware-based investors in biopharmaceutical firm CytRx Corp. urged the Chancery Court to keep their derivative action moving on Monday, saying the case raises unprecedented questions about the rights of companies and their directors to waive their forum choices for lawsuits....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!